A Study to Compare Adaptive Support Ventilation vs. Volume Controlled Ventilation for Management of Respiratory Failure in Patients With Neuroparalytic Snake Envenomation
ASV vs VCV in
1 other identifier
interventional
50
1 country
1
Brief Summary
Neuroparalytic snake envenomation results in severe muscle weakness and respiratory failure. Treatment requires administration of anti-snake venom and supportive care in the form of invasive mechanical ventilation. Whether using adaptive support ventilation (a closed loop mode of ventilation) in comparison to volume controlled ventilation will shorten the duration of ventilation remains undetermined. The current study is planned to compare adaptive support ventilation (ASV) mode of ventilation versus volume controlled ventilation (VCV) during invasive mechanical ventilation for the management of respiratory failure secondary to neuroparalytic snake envenomation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2016
CompletedFirst Posted
Study publicly available on registry
August 24, 2016
CompletedStudy Start
First participant enrolled
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2020
CompletedApril 20, 2022
April 1, 2022
3.2 years
August 17, 2016
April 19, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Liberation from mechanical ventilation
Liberation from mechanical ventilation (defined as time \[in hours\] between intubation to extubation for at least six hours)
28 days after discharge
Secondary Outcomes (4)
Incidence of ventilator associated pneumonia
28 days after discharge
Post extubation respiratory failure
28 days after discharge
In hospital mortality
28 days after discharge
ICU and hospital length of stay
28 days after discharge
Study Arms (2)
Adaptive support ventilation
EXPERIMENTALadaptive support ventilation mode during invasive mechanical ventilation
Volume controlled ventilation
ACTIVE COMPARATORVolume controlled ventilation during invasive mechanical ventilation
Interventions
Adaptive support ventilation during invasive mechanical ventilation
Volume controlled ventilation during invasive mechanical ventilation
Eligibility Criteria
You may qualify if:
- Need for invasive mechanical ventilation for management of respiratory failure
- age group of 12 to 90 years
- ability to provide informed consent to participate in the study
You may not qualify if:
- Cardiorespiratory arrest requiring cardiopulmonary resuscitation
- pregnancy
- failure to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Respiratory ICU, Post Graduate Institue of Medical Education and Research
Chandigarh, 160012, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ritesh Agarwal, MD,DM
PGIMER,Chandigarh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Department of Pulmonary Medicine
Study Record Dates
First Submitted
August 17, 2016
First Posted
August 24, 2016
Study Start
December 1, 2016
Primary Completion
January 31, 2020
Study Completion
January 31, 2020
Last Updated
April 20, 2022
Record last verified: 2022-04